Ampleia

Ampleia is a dynamic venture-building organization focused on driving exceptional advancements in rare disease therapeutics. By collaborating with leading scientists and entrepreneurs, Ampleia is dedicated to developing innovative therapeutic options for underserved indications. Acting as an operating co-founder from the outset, Ampleia provides crucial funding, translational development capabilities, and corporate support.

Located at 1 BIS RUE DE L'INTERNATIONALE, EVRY-COURCOURONNES, 91000, FR, Ampleia is committed to making strategic decisions that prepare founders and companies for Series A funding or strategic deals. With a technology-agnostic approach, Ampleia supports projects globally, ensuring the most promising advancements reach those in need.

Ampleia continues to expand its reach and impact in the biotechnology sector. The team is diligently working to complete additional company information, which will soon be available with the support of Ampleia's management. We invite the manager of Ampleia to create a customized and exclusive company showcase and product listing on our platform.